Matinas BioPharma Holdings, Inc.
MTNB
$2.13
$0.3922.41%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -216.73% | 80.36% | -97.26% | 25.25% | 1.80% |
| Total Depreciation and Amortization | -4.69% | -48.18% | 1.23% | 1.24% | 0.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -200.00% |
| Total Other Non-Cash Items | 16,961.90% | -99.54% | 374.17% | -0.41% | -2.31% |
| Change in Net Operating Assets | 3.80% | -681.40% | 119.68% | -130.82% | 218.36% |
| Cash from Operations | -0.70% | 42.82% | -0.29% | -12.69% | 46.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -94.82% | 428.32% | -246.90% |
| Cash from Investing | -- | -- | -94.82% | 428.32% | -246.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 50.00% | -100.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | 16,918.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -201.76% | -- | -- | -- | -- |
| Cash from Financing | -1.52% | 164,800.00% | 98.51% | -100.73% | 17,237.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.83% | 88.04% | -149.53% | 93.29% | 184.63% |